1-2 of 2
Diana Samson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long Term Follow-Up Shows No Clinical Benefit for CD34 + Selection of Autologous Transplants Following Myeloablative Therapy in Patients with Newly Diagnosed Myeloma : An EBMT Phase III Randomized Study.

Jean-Henri Bourhis, MD, Yasmina Bouko, MD, Serge Koscielny, PhD, Hildegard Greinix, MD, Gunter Derigs, MD, Gilles Salles, MD, Walter Feremans, MD, Marleen Bakkus, PhD, Jane Apperley, MD, Diana Samson, MD, Bo Bjorkstrand, MD, Dietger Niederwieser, MD, Gosta Gahrton, MD, Jose-Luis Pico, MD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2004) 104 (11): 921.
https://doi.org/10.1182/blood.V104.11.921.921
Published: 2004
Journal Articles

Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma

Brief Report
Paolo Corradini, Michele Cavo, Henk Lokhorst, Giovanni Martinelli, Carolina Terragna, Ignazio Majolino, Pinuccia Valagussa, Mario Boccadoro, Diana Samson, Andrea Bacigalupo, Nigel Russell, Vittorio Montefusco, Claudia Voena, Gosta Gahrton, the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
Journal: Blood
Blood (2003) 102 (5): 1927–1929.
https://doi.org/10.1182/blood-2003-01-0189
Published: 2003